title: [Implications of modern anticancer therapies for palliative care concepts].
abstract: In modern oncology, paradigmatic developments can be witnessed with respect to conceptual strategies and to individualized diagnostics and treatment approaches, but foremost with respect to the amazing number of new anticancer substances available. These developments will certainly influence the care of patients suffering from incurable and advanced cancer, where pain therapy and symptom control, quality of life and other intentions of palliative care are urgent. For cancer pain therapy and palliative care, knowledge about these developments may be helpful not only with respect to interdisciplinary decision making, but also for thoroughly balancing risks, side effects and benefits of oncological interventions that have the potential to stabilize disease progression and thereby reduce symptom intensity.
authors.affiliation: Abteilung Palliativmedizin, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Deutschland. bernd.alt-epping@med.uni-goettingen.de
authors.forename: B
authors.initials: B
authors.lastname: Alt-Epping
authors.forename: F
authors.initials: F
authors.lastname: Nauck
mesh_terms: D000203:Activities of Daily Living / Q000523:psychology; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003299:Cooperative Behavior; D018450:Disease Progression; D016503:Drug Delivery Systems; D006801:Humans; D033183:Interdisciplinary Communication; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology*; D010146:Pain / Q000523:psychology*; D059408:Pain Management; D010166:Palliative Care / Q000379:methods* / Q000523:psychology*; D017060:Patient Satisfaction; D018802:Patient-Centered Care; D011788:Quality of Life / Q000523:psychology*; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents